2251 — Beijing Airdoc Technology Co Balance Sheet
0.000.00%
- HK$1.37bn
- HK$722.41m
- CNY156.37m
- 24
- 19
- 80
- 33
Annual balance sheet for Beijing Airdoc Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 375 | 1,785 | 1,413 | 1,142 | 775 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19.8 | 37.3 | 70.7 | 89 | 77.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 409 | 1,846 | 1,676 | 1,282 | 894 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 23.2 | 45 | 33.1 | 28.4 | 18.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 436 | 1,894 | 1,740 | 1,685 | 1,411 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 24.9 | 70.8 | 64.7 | 110 | 122 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 27.5 | 74.2 | 73.8 | 145 | 143 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 408 | 1,820 | 1,666 | 1,540 | 1,269 |
| Total Liabilities & Shareholders' Equity | 436 | 1,894 | 1,740 | 1,685 | 1,411 |
| Total Common Shares Outstanding |